Skip to main content
Search
Search
Enter the terms you wish to search for.
Login
About Us
Organisation
Blog
Articles of Association
ISBLRT
Privacy Policy
SITEC
SITIS
Time to Support
Events and Delegations
Events
Membership
Become a member
Membership Directory
Benefits and Services
Resources
News
photo gallery
Video Gallery
Publication
Contact Us
Login
Register
About Us
Organisation
Blog
Articles of Association
ISBLRT
Privacy Policy
SITEC
SITIS
Time to Support
Events and Delegations
Events
Membership
Become a member
Membership Directory
Benefits and Services
Resources
News
photo gallery
Video Gallery
Publication
Contact Us
About Us
Organisation
Blog
Articles of Association
ISBLRT
Privacy Policy
SITEC
SITIS
Time to Support
Events and Delegations
Events
Membership
Become a member
Membership Directory
Benefits and Services
Resources
News
photo gallery
Video Gallery
Publication
Contact Us
Home
news
anocca license emendobios gene editing technology
Anocca to license EmendoBio’s gene editing technology
March 19, 2024
Source:
Swedish biotech company Anocca has entered a non-exclusive licensing agreement with EmendoBio to use the latter’s OMNI-A4 nuclease, a gene editing technology [that cleaves chains of nucleotides in nucleic acids into smaller units]. This strategic move is
Share this on